These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 1445318)

  • 21. Regulation of cytoplasmic calcium concentration in tetracycline-treated osteoclasts.
    Donahue HJ; Iijima K; Goligorsky MS; Rubin CT; Rifkin BR
    J Bone Miner Res; 1992 Nov; 7(11):1313-8. PubMed ID: 1466256
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Tetracycline derivatives inhibit cartilage degradation in cultured embryonic chick tibiae.
    Orth MW; Chlebek KA; Cole AA; Schmid TM
    Res Vet Sci; 1997; 63(1):11-4. PubMed ID: 9368950
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Inhibition of trypsin-like cysteine proteinases (gingipains) from Porphyromonas gingivalis by tetracycline and its analogues.
    Imamura T; Matsushita K; Travis J; Potempa J
    Antimicrob Agents Chemother; 2001 Oct; 45(10):2871-6. PubMed ID: 11557483
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Doxycycline and other tetracyclines in the treatment of bone metastasis.
    Saikali Z; Singh G
    Anticancer Drugs; 2003 Nov; 14(10):773-8. PubMed ID: 14597870
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effects of tetracyclines on experimental Legionella pneumophila infection in guinea-pigs.
    Yoshida S; Mizuguchi Y; Ohta H; Ogawa M
    J Antimicrob Chemother; 1985 Aug; 16(2):199-204. PubMed ID: 4066557
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Tetracyclines inhibit human synovial collagenase in vivo and in vitro.
    Greenwald RA; Golub LM; Lavietes B; Ramamurthy NS; Gruber B; Laskin RS; McNamara TF
    J Rheumatol; 1987 Feb; 14(1):28-32. PubMed ID: 3033237
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Aerobic and anaerobic susceptibility tests with three tetracyclines. Reassessment of the "class concept" of disk testing.
    Barry AL; Draper DL; Wong MK
    Am J Clin Pathol; 1978 Nov; 70(5):821-5. PubMed ID: 717289
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Part X. Tetracycline and glycylcycline antimicrobials.
    Vincent S; Bronze MS; Cooper TW; Greenfied RA
    J Okla State Med Assoc; 2007 Jun; 100(6):241-7. PubMed ID: 17708423
    [No Abstract]   [Full Text] [Related]  

  • 29. The in-vitro activity of doxycycline and minocycline against anaerobic bacteria.
    Robbins M; Marais R; Felmingham D; Ridgway GL
    J Antimicrob Chemother; 1987 Sep; 20(3):379-82. PubMed ID: 3680075
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A non-antibacterial chemically-modified tetracycline inhibits mammalian collagenase activity.
    Golub LM; McNamara TF; D'Angelo G; Greenwald RA; Ramamurthy NS
    J Dent Res; 1987 Aug; 66(8):1310-4. PubMed ID: 3040832
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Inhibition of proteolytic, serpinolytic, and progelatinase-b activation activities of periodontopathogens by doxycycline and the non-antimicrobial chemically modified tetracycline derivatives.
    Grenier D; Plamondon P; Sorsa T; Lee HM; McNamara T; Ramamurthy NS; Golub LM; Teronen O; Mayrand D
    J Periodontol; 2002 Jan; 73(1):79-85. PubMed ID: 11846203
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Comparison of the efficacy of various concentrations and combinations of serum, ethylenediaminetetraacetic acid, tetracycline, doxycycline, minocycline, and N-acetylcysteine for inhibition of collagenase activity in an in vitro corneal degradation model.
    Kimmitt BA; Moore GE; Stiles J
    Am J Vet Res; 2018 May; 79(5):555-561. PubMed ID: 29688786
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Cytotoxic effects of tetracycline analogues (doxycycline, minocycline and COL-3) in acute myeloid leukemia HL-60 cells.
    Song H; Fares M; Maguire KR; Sidén A; Potácová Z
    PLoS One; 2014; 9(12):e114457. PubMed ID: 25502932
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Tetracyclines inhibit tissue collagenases. Effects of ingested low-dose and local delivery systems.
    Golub LM; Goodson JM; Lee HM; Vidal AM; McNamara TF; Ramamurthy NS
    J Periodontol; 1985 Nov; 56(11 Suppl):93-7. PubMed ID: 3001266
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Inhibition of MMP synthesis by doxycycline and chemically modified tetracyclines (CMTs) in human endothelial cells.
    Hanemaaijer R; Visser H; Koolwijk P; Sorsa T; Salo T; Golub LM; van Hinsbergh VW
    Adv Dent Res; 1998 Nov; 12(2):114-8. PubMed ID: 9972133
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effects of doxycycline, minocycline, and tetracycline on cell proliferation, differentiation, and protein expression in osteoprecursor cells.
    Park JB
    J Craniofac Surg; 2011 Sep; 22(5):1839-42. PubMed ID: 21959447
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effect of therapeutic levels of doxycycline and minocycline in the proliferation and differentiation of human bone marrow osteoblastic cells.
    Gomes PS; Fernandes MH
    Arch Oral Biol; 2007 Mar; 52(3):251-9. PubMed ID: 17141175
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Non-antibiotic properties of tetracyclines and their clinical application in dermatology.
    Perret LJ; Tait CP
    Australas J Dermatol; 2014 May; 55(2):111-8. PubMed ID: 23808657
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Mechanism of inhibitory actions of minocycline and doxycycline on ascitic fluid production induced by mouse fibrosarcoma cells.
    Wakai K; Ohmura E; Satoh T; Murakami H; Isozaki O; Emoto N; Demura H; Shizume K; Tsushima T
    Life Sci; 1994; 54(11):703-9. PubMed ID: 8107519
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Tetracyclines inhibit nitrosothiol production by cytokine-stimulated osteoarthritic synovial cells.
    Borderie D; Hernvann A; Hilliquin P; Lemarchal H; Kahan A; Ekindjian OG
    Inflamm Res; 2001 Aug; 50(8):409-14. PubMed ID: 11556521
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.